-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is LumiraDx (LMDX) Stock Down 13% Today?
LumiraDx stock is falling hard on Monday as investors in LMDX prepare for the company's shares to be delisted on Tuesday!
Why Is Cellectar Biosciences (CLRB) Stock Up 16% Today?
Cellectar Biosciences stock is up on Monday as investors celebrate positive study results with heavy trading of CLRB stock this morning.
Why Is Harpoon Therapeutics (HARP) Stock Up 111% Today?
Harpoon Therapeutics stock is rocketing higher on Monday as HARP investors react to Merck acquiring the company for $23 per share.
$10K to $100K: Small-Cap Marvels With Massive Upside
Unlocking the potential of small-cap companies often reveals sky-bound stocks. The three listed stocks in the article offer substantial growth opportunities.
Allogene Layoffs 2024: What to Know About the Latest ALLO Job Cuts
Today, investors in Allogene and ALLO stock aren't cheering a cash burn reduction strategy, with the stock sinking over 15% on the news.
New SAVAW Warrants Are Trading After Cassava Sciences’ Distribution
Following a distribution, investors in Cassava Sciences and SAVA stock now have some warrants to factor into their models today.
HGEN Stock Alert: Why Humanigen Just Filed for Ch. 11 Bankruptcy
Humanigen stock is falling hard on Friday as investors in HGEN sell shares after the company announced a bankruptcy filing.
AlloVir Layoffs 2024: What to Know About the Latest ALVR Job Cuts
AlloVir layoffs are coming for 95% of the company's employees as a way to reduce costs and preserve cash after failed clinical trials.
Why Is Medical Properties Trust (MPW) Stock Down 31% Today?
Medical Properties Trust stock is falling hard on Friday as investors in MPW react to a rent repayment plan with Steward Health Care System.
Intellia Therapeutics Layoffs 2024: What to Know About the Latest NTLA Job Cuts
Intellia Therapeutics layoffs are in the news on Friday as the biotech company prepares to cut its total workforce by 15% to reduce costs.
Why Is Applied Therapeutics (APLT) Stock Down 30% Today?
Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.
Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today?
Dermata Therapeutics stock is heading higher on Friday as investors of DRMA shares react to a new patent for DMT410 in Japan.
Why Is Ainos (AIMD) Stock Up 157% Today?
Ainos stock is up on Friday as shares of AIMD see heavy trading despite a lack of news from the healthcare company today.
Tilray’s Downfall: Why TLRY Stock Isn’t the High Investors Hoped For
With its share price down 92% since its 2018 market debut, and now trading as a penny stock, there doesn't appear to be much hope left for cannabis producer Tilray Brands.